期刊文献+

甲基化抑制剂5-氮杂胞苷对HL-60细胞增殖及凋亡的影响 被引量:2

5-Aza-cytidine inhibit proliferation of human promyelocytic leukemia cells (HL60) by inducing apoptosis
下载PDF
导出
摘要 目的:观察5-氮杂胞苷对髓系白血病细胞系HL-60的增殖抑制作用,探讨其对细胞周期、细胞凋亡的影响。方法:常规方法培养HL-60细胞,加入不同浓度的5-氮杂胞苷,以MTT法测定对HL-60的抑制作用,计算细胞生长抑制率;流式细胞术检测小剂量5-氮杂胞苷处理HL-60细胞后48h的细胞凋亡率及细胞周期分布特点。结果:不同浓度5-氮杂胞苷均可以不同程度的抑制细胞生长,且表现为时间、浓度依赖性。在小剂量浓度5-氮杂胞苷处理HL-60细胞48h后,随着5-氮杂胞苷浓度的增加,凋亡细胞百分比逐渐增多(P<0.05);G1期细胞逐渐增多,S期细胞减少,G2/M期细胞相对增多,细胞阻滞在G1期。结论:5-氮杂胞苷对髓系白细胞细胞系HL-60的生长抑制表现为浓度和时间依赖性,一定剂量的5-氮杂胞苷诱导细胞凋亡,使细胞阻滞在G1期。 Objevtive:This study was aimed to investigate the effect of 5-aza-cytidine on the proliferation,cell cycles distribution profile and apoptosis of human promyelocytic cell line HL60.Methods: The human promyelocytic cell line HL-60 was cultured in RPMI 1640 medium.3-(4,5-Dimethylthiazol-2-y)l-2,5-diphenylte trazolium(MTT)reduction by cells was used to assess drug-induced cell growth inhibition.Cells were treated with 0.25,0.5,1,2.5μmol/L of freshly prepared 5-aza-cytidine for 48 hours before they were harvested for analyzing distribution of cell cycle phases and apoptosis by flow cytometer.Results:5-aza-cytidine inhibited HL60 cell proliferation in a time-and concentration-dependent manner.Apoptosis was induced as detected by flow cytometry.Determination of the cell cycle distribution by flow cytometry revealed an accumulation of cells in G1 phase.Conclusion:DNA methylation inhibitor 5-aza-cytidine has effects on proliferation of human promyelocytic cell line HL60.Possible mechanism of this inhibition is induction of apoptosis.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第7期981-984,共4页 Journal of Chongqing Medical University
基金 重庆市卫生局科研基金资助项目(编号:渝卫科教34号06-2-193)
关键词 基因甲基化 5-氮杂胞苷 白血病 凋亡 细胞周期 Gene methylation 5-aza-Cytidine Leukemia Cell cycle Apoptosis
  • 相关文献

参考文献11

  • 1Michael T M,Johann C B,and Paula M V.Cancer DNA methylation:Molecular mechanisms and clinical implications[J].Clin.Cancer Res,2009,15(12):3927-3937.
  • 2Issa J-P J.DNA methylatinn as a therapeutic target in cancer[J].Clinical Cancer Research,2007,13(6):1634-1637.
  • 3Piskala A,Sorm F.5-Azacytidine,a new highly effective cancer ostatic[J].Experientia,1964,20(4):202-203.
  • 4Glover A B,Leyland J B.Biochemistry of azacytidine:a review[J].Cancer Treat Rep,1987,71(10):959-964.
  • 5Kaminskas E.Farrell A.Abraham S,et al.Approval summary:Azacytidine for treatment of myelodysplastic syndrome subtypes[J].Clin Cancer Res,2005,11(10):3604-3608.
  • 6Chitambar C R,Libnoch J A,Matthaeus W G,et al.Evaluation of continuous infusion low dose 5-azacytidine in the treatment of myelodysplastic syndromes[J].Am J Hematol,1991,37(2):100-104.
  • 7Kaminskas E.FDA drug approval summary:azacytidine (5-azacytidine,vidaza (tm))for injectable suspension[J].Oncologist,2005,10(3):176-182.
  • 8刘建秋,李爱敏,张继红.5-氮杂胞苷增强阿霉素对神经母细胞瘤细胞的抗瘤活性[J].中国当代儿科杂志,2007,9(6):577-579. 被引量:2
  • 9Kang D W,Choi C H,Park J Y,et al.Ciglitazone induces caspase independent apoptosis through down regulation of xiap and survivin in human glioma cells[J].Neurochem Res,2008,33(3):551-561.
  • 10Murakami T,Li X,Gong J,et al.Inductinn of apoptosis by 5 azacytidine:drug concentration-dependent differences in cell cycle specificity[J].Cancer Res,1995,55(14):3093-3098.

二级参考文献9

  • 1Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikeqaki N, et al. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma ceils correlates with a loss of caspase-8 expression [ J ]. Cancer Res, 2001 , 61 (4) :1314-1319.
  • 2Pingoud-Meier C, Lang D, Janss A J, Rorke LB, Phillips PC, Shalaby T, et al. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma [J]. Clin Cancer Res, 2003, 9(17) :6401-6409.
  • 3Harada K,Toyooka S, Shivapurkar N, Maitra A, Reddy JL, Matta H, et al. Deregulation of caspase-8 and 10 expression in pediatric tumors and cell lines [ J ]. Cancer Res, 2002, 62 (20) : 5897- 5901.
  • 4Gonzalez-Gomez P, Bello M J, Inda MM, Alonso ME, Arjona D, Aminoso C, et al. Deletion and aberrant CpG island methylation of caspase 8 gene in medulloblastoma [ J ]. Oncol Rep, 2004, 12 ( 3 ) :663-666.
  • 5Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, et al. Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction [ J ]. Cancer Res, 2005, 65 ( 24 ) .. 11469-11477.
  • 6Wu J, Harris NL, Inqe TH. Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells[J]. J Surg Res, 2004, 122(2) :231-239.
  • 7Hopkins-Donaldson S, Yan P, Boudoud KB. MuhlethalerA, Bodmet JL, Gross N. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells[J]. Oncogene, 2002, 21(39): 6132- 6137.
  • 8Ribas J, Gomez-Arbones X, Boix J. Caspase-8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibiting drugs[ J]. Eur J Parmacol, 2005, 524( 1-3): 49-52.
  • 9Bian X, McAllister-Lucas LM, Shao F, Schumacher KR, Fenq Z, Porter AG, et al. NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma ceils [J]. J Biol Chem, 2001,276(52): 48921-48929.

共引文献1

同被引文献32

  • 1罗建民,刘泽林,郝洪岭,董作仁,王福旭,大野竜三.急性白血病细胞HCP基因的突变分析[J].临床血液学杂志,2004,17(5):271-273. 被引量:6
  • 2韩颖,罗建民,贾晓辉,王福旭,姚丽,杜行严.急性白血病患者SHP-1与c-kit基因表达及其临床意义[J].中国实验血液学杂志,2006,14(5):867-871. 被引量:7
  • 3Issa J P.DNA methylation as a therapeutic target in cancer[J].Clin Cancer Res, 2007,13 (6) : 1634-1637.
  • 4Ellis L,Atadja P W,Johnstone R W,Epigenetics in cancer: target- ing chromatin modifications[J].Mol Cancer Ther, 2009,8 ( 6 ) : 1409-1420.
  • 5Kaminskas E,Farrell A T,Wang Y C,et al.FDA drug approval sum- mary :azacytidine(5-azacytidine, vidaza) for injectable suspension[J].On- cologist,2005,10(3) : 176-182.
  • 6Fenaux P, Mufti G J, Hellstrooro-Lindberg E,et al.Efficacy of azac- itidine compared with that of conventional care regimens in the treat- ment of higher-risk royelodysplastic syndromes: a randomised,open-la- bel,phase 111 study[J].Lancet Oncol,2009,10(3) :223-232.
  • 7Liu Y, Johnson S M, Fedoriw Y, et aI.Expression of p 16INK4a pre- vents cancer and promotes aging in |ymphocytes[J].B|ood,2011,117(12) : 3257-3267.
  • 8Lin Y, Hupp T R,Stevens C.Death-associated protein kinase (DAPK) and signal transduction: additional roles beyond cell death[J]. FEBS J, 2010,277( 1 ) :48-57.
  • 9Qian J,Wang Y L,Lin J,et al.Aberrant methylation of the death- associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia[J].Eur J Haematol, 2009,82 (2) : 119-123.
  • 10Liu L, Gerson S L.Targeted modulation of MGMT:clinical implica- tions [J].Clin Cancer Res, 2006,12(2) : 328-331.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部